-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_surveillance.pdf
August 01, 2012 - for Updating Systematic Reviews for the EHC Program
CER # 20:
Comparative effectiveness and safety … KQ4 up to date
• Expert opinion: conclusions for KQ1-4 still valid
• There are no new significant safety … up to date
• Expert opinion: conclusions for KQ1-4 are still valid
• There are no new significant safety … FDA surveillance alerts (Cycle 2): No relevant safety alerts.
10
1st Assessment Conclusion: … Comparative effectiveness and safety of
radiotherapy treatments for head and neck
cancer.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_executive.pdf
June 01, 2013 - Scope and Key Questions
This CER was funded by AHRQ and is designed to
evaluate the comparative safety … Specifically:
• KQ 1: What are the comparative safety and
effectiveness of pharmacological agents … • KQ 2: What are the comparative safety and
effectiveness of a strict rate-control strategy versus … Do the comparative safety and effectiveness of these
therapies differ among specific patient subgroups … • Data are also insufficient as to whether the safety and
effectiveness of these therapies differ
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-chronic-pain-surveillance-report-2.pdf
April 01, 2022 - Safety Events Associated with Tramadol
Use Among Older Adults with
Osteoarthritis. … Safety Events Associated with Tramadol
Use Among Older Adults with
Osteoarthritis. … Predicting opioid therapy safety in
pancreatic cancer patients. … Safety and efficacy
of the unique opioid buprenorphine for the
treatment of chronic pain. … Efficacy and safety of morphine
hydrochloride in cancer patients with
chronic pain.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
January 01, 2020 - However,
safety concerns emerged from key informant discussions, including unknown long-term harms … Some platforms have safety features, such as a handrail for balance. … Vibration exposure, therapeutic and occupational, presents safety concerns. … A number of safety issues for consumers, including safety features available on the devices
and the … Upper gastrointestinal tract safety of
risedronate: a pooled analysis of 9 clinical
trials.
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - data and postmarket safety evaluation—set
forth by FDA.23,24 Until mid-2012, orlistat, a pancreatic … data and postmarket safety evaluation—set
forth by FDA.23,24 Until mid-2012, orlistat, a pancreatic … If liraglutide demonstrates safety and long-term efficacy, it could fulfill a large unmet
14 … data and postmarket safety evaluation—set forth by FDA. … A prospective,
randomized multicenter study to evaluate the
safety and efficacy of the ReShape Duo
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2022.pdf
January 01, 2022 - Department of Transporation National Highway Traffic Safety
Administration (NHTSA). … The modifying effect of the serum-to-dialysate
potassium gradient on the cardiovascular safety of SSRIs … Patient Safety Practices To Address Harms Resulting From Patient-Clinician Real-Time Clinical
Encounters … Patient Safety Practices To Address Harms Resulting From Patient-Clinician Real-Time Clinical
Encounters … Agency for Healthcare Research and Quality (AHRQ) – Center for Quality Improvement and Patient
Safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gaps-pain-management.pdf
January 01, 2023 - Explanatory and pragmatic trials with long-term
followup to evaluate differential effectiveness
and safety … Study Design
• Longitudinal explanatory and pragmatic trials to
evaluate effectiveness and safety … Design
• Trials with sufficient sample size designed to
evaluate differential effectiveness and safety … • Studies with sufficient size to evaluate
differential effectiveness and safety of
treatments in … products/acute-pain-ems/research
Purpose
This report, nominated by the National Highway Traffic Safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
June 01, 2011 - adult patients with essential
hypertension, how do ACEIs, ARBs, and direct renin
inhibitors differ in safety … For RCTs, this translates to a difference in
renin inhibitors differ in safety, Insufficient rates of … For RCTs, this translated to an absolute difference in
renin inhibitors differ in safety, ARB); withdrawals … major cardiovascular events [myocardial infarction (MI), stroke] and measures of quality of life).
• Safety … (For practical reasons, we separate safety/adverse events and tolerability/persistence [including switch
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1506.pdf
November 01, 2016 - GnRH receptor agonists, some
of which are available in generic formulations, if it shows improved safety … A clinical study to evaluate the safety and
efficacy of elagolix in subjects with moderate to
severe … Study to evaluate the long-term safety
and efficacy of elagolix in subjects with moderate
to severe … A global phase 3 study to evaluate the
safety and efficacy of elagolix in subjects with
moderate … Global study to evaluate the long-term
safety and efficacy of elagolix in subjects with
moderate
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
April 06, 2010 - Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness and Safety … Key Question 3: In adults age 18 or older with type 2 diabetes mellitus, what is the comparative
safety … Macular edema or decreased vision
Gastrointestinal (GI) side effects
Key Question 4: Do safety … Outcomes include intermediate outcomes, long-term outcomes, safety, adverse
events, mortality, and quality … Comparative Effectiveness and Safety of Oral Diabetes
Medications for Adults With Type 2 Diabetes.
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1512.pdf
November 01, 2016 - GnRH receptor agonists, some of which are
available in generic formulations, if it shows improved safety … Study to evaluate the long-term safety
and efficacy of elagolix in subjects with moderate
to severe … A global phase 3 study to evaluate the
safety and efficacy of elagolix in subjects with
moderate … Global study to evaluate the long-term
safety and efficacy of elagolix in subjects with
moderate … A clinical study to evaluate the safety and
efficacy of elagolix in subjects with moderate to
severe
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-anticholinergic-medicines_research.pdf
December 01, 2009 - patients, and policymakers
seeking unbiased information about the outcomes, clinical effectiveness, safety … Methodologic challenges to
studying patient safety and comparative
effectiveness. … Pooled clinical trial analysis of
tiotropium safety. Chest 2006
Dec;130(6):1695-703.
20. … The multiple
propensity score for analysis of dose-
response relationships in drug safety
studies. … Methodologic challenges to
studying patient safety and comparative
effectiveness.
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
July 01, 2013 - safety evaluation. … data
and postmarket safety evaluation—set forth by FDA. … If liraglutide demonstrates safety and long-term efficacy, it could fulfill a large unmet
need. … data and postmarket safety evaluation—set forth by FDA. … A prospective,
randomized multicenter study to evaluate the
safety and efficacy of the ReShape Duo
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-adults_executive.pdf
August 01, 2012 - Tables with a summary of findings for efficacy and safety
are presented below. … Summary of the strength of evidence for medication-associated
adverse events and safety (KQ3)
Adverse … In general, the findings for
AEs were consistent between reviews, showing poorer
safety profiles with … focused on the comparative effectiveness
of FGAs versus SGAs, but not on their effectiveness and
safety … Finally, data on
long-term safety are lacking and urgently needed.
14
References
1.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/progestogens-preterm-birth_research-protocol.pdf
June 01, 2010 - be supported, including its mechanism of action, clinical indications,
optimal forms, dosing, and safety … of gestation, because unresolved issues such as optimal
route of drug delivery and long-term drug safety … sepsis)
• Longer term outcomes
Question 3
How do the effectiveness, adverse effects, and safety … Question 4
How do the effectiveness, acceptability, adherence, adverse effects, and safety of progestogen … Question 5
How do the effectiveness, adverse effects, and safety of progestogen treatment differ based
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
April 18, 2013 - Reviewer 3 ES: Treatment safety is
defined by the rates of
adverse effects that lead to
treatment … not true, it also includes all AE reports We revised this sentence as follows:
“Treatment safety is … Pediatric safety trials should
examine adverse effects at 12 months or more. … safety but no efficacy report. to what purpose? … effects) rather than “general safety” or
“reasonable tolerability” of the drugs.
-
effectivehealthcare.ahrq.gov/sites/default/files/it-architecture-for-post-marketing-surveillance-arizona-cert.pdf
September 01, 2007 - Keywords: Adverse event reporting, community pharmacy safety network, post-marketing
surveillance … The DERMS system is based on a
community pharmacy based safety network and involves the participation … reviewers and researchers on a quarterly basis
for analyzing drug interactions and monitoring drug safety … part of the CPSN, the DERMS system can be adapted to serve as a general pharmacy based
patient safety … In the case of confirmed adverse effects, a report can be sent to the FDA’s office of
drug safety.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
March 01, 2013 - While frequentist and Bayesian analyses produced broadly comparable odds ratios of
safety and efficacy … As such, treatment decisions should be made based on
comparative safety of the drugs. … Efficacy and safety of tolterodine in patients
with detrusor instability: a dose-ranging
study. … Efficacy and safety of tolterodine in patients
with detrusor instability: a dose-ranging
study. … Efficacy, safety and tolerability of
fesoterodine for overactive bladder
syndrome.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-testing-machine-learning-tool-chronic-pain.pdf
November 01, 2020 - A 1-year safety and efficacy study of duloxetine in
patients with fibromyalgia. … Evaluation of efficacy and safety of gabapentin,
duloxetine, and pregabalin in patients with painful … Comparative safety and tolerability of duloxetine vs. … Effectiveness and safety of Tapentadol Prolonged
Release (PR) versus a combination of Tapentadol PR … A multicenter, randomized, double-blind, placebo-controlled
trial to assess the efficacy and safety
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-careassociated-infections_executive.pdf
November 01, 2012 - practices:8
• Theory behind patient safety practice
• Existing patient safety infrastructure
• External … patient safety culture and teamwork at the unit level. … Assessing the Evidence
for Context-Sensitive Effectiveness and Safety of Patient
Safety Practices: … Advancing
the science of patient safety. Ann Intern Med. 2011 May
17;154(10):693-6. … What are the most effective strategies for improving
quality and safety of health care?